SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000899140-16-001336
Filing Date
2016-03-28
Accepted
2016-03-28 16:55:39
Documents
2
Group Members
TEVA PHARMACEUTICALS USA, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G t16672971a.htm SC 13G 110950
2 JOINT FILING AGREEMENT t16672971b.htm EX-99.1 9518
  Complete submission text file 0000899140-16-001336.txt   122108
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filed by) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Subject) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82505 | Film No.: 161532746
SIC: 2834 Pharmaceutical Preparations